anmelden
DAXglobal Sarasin Sustainability Germany Index EUR
2.143,93
PKT
+0,56
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu DAXglobal Sarasin Sustainability Germany Index EUR-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.01.24 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
| 10.01.24 | Fresenius Medical Care (FMC) St. Neutral | UBS AG | |
| 10.01.24 | Fresenius Buy | UBS AG | |
| 10.01.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 10.01.24 | SAP Buy | UBS AG | |
| 10.01.24 | Henkel vz. Underperform | Bernstein Research | |
| 10.01.24 | Beiersdorf Market-Perform | Bernstein Research | |
| 10.01.24 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 10.01.24 | Infineon Buy | Jefferies & Company Inc. | |
| 10.01.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.24 | Infineon Buy | Warburg Research | |
| 10.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 10.01.24 | Symrise Market-Perform | Bernstein Research | |
| 10.01.24 | Evonik Outperform | Bernstein Research | |
| 10.01.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 09.01.24 | Evonik Hold | Jefferies & Company Inc. | |
| 09.01.24 | Siemens Outperform | Bernstein Research | |
| 09.01.24 | BMW Outperform | Bernstein Research | |
| 09.01.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.01.24 | Roche Equal Weight | Barclays Capital | |
| 09.01.24 | Merck Buy | Jefferies & Company Inc. | |
| 09.01.24 | Siemens Outperform | Bernstein Research | |
| 09.01.24 | Deutsche Börse Neutral | Goldman Sachs Group Inc. | |
| 09.01.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 09.01.24 | adidas Overweight | JP Morgan Chase & Co. | |
| 09.01.24 | Fresenius Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Fresenius Medical Care (FMC) St. Underweight | JP Morgan Chase & Co. | |
| 09.01.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.01.24 | NORMA Group Hold | Hauck & Aufhäuser Privatbankiers KGaA | |
| 09.01.24 | Givaudan Market-Perform | Bernstein Research | |
| 09.01.24 | Hannover Rück Outperform | RBC Capital Markets | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Infineon Outperform | Bernstein Research | |
| 08.01.24 | Fresenius Medical Care (FMC) St. Market-Perform | Bernstein Research | |
| 08.01.24 | HUGO BOSS Outperform | RBC Capital Markets | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 08.01.24 | Bechtle Buy | Warburg Research | |
| 08.01.24 | Richemont Sector Perform | RBC Capital Markets |